Anti-inflammatory effects of ivermectin in mouse model of allergic asthma
Shuhan Yan, Xinxin Ci, Na Chen, Chi Chen, Xiangchao Li, Xiao Chu, Jianhua Li, Xuming Deng
Inflammation Research, doi:10.1007/s00011-011-0307-8
Background and objective Asthma is an inflammatory disease of the lungs that is characterised by increased inflammatory cell infiltration into the airways and poor respiratory function. Ivermectin is a semi-synthetic derivative of a family of macrocyclic lactones that shows broad-spectrum anti-parasitic activity. This drug has been shown to possess anti-inflammatory activity, but whether it can be used in asthma treatment has not yet been investigated. In this study, we aimed to investigate the inhibitory effects of ivermectin on allergic asthma symptoms in mice.
Methods and results We used a mouse asthma model, in which allergic airway inflammation and airway remodelling were induced by ovalbumin (OVA) sensitisation and challenge. Ivermectin or PBS treatment was administered 1 h before OVA challenge. Ivermectin at 2 mg/kg significantly diminished recruitment of immune cells, production of cytokines in the bronchoalveolar lavage fluids and secretion of OVA-specific IgE and IgG1 in the serum. Histological studies indicated that ivermectin suppressed mucus hypersecretion by goblet cells in the airway. Conclusions This is the first study to demonstrate that ivermectin is an effective suppressor of inflammation and may be efficacious in the treatment of non-infectious airway inflammatory diseases such as allergic asthma.
References
Abu-Ghazaleh, Kita, Gleich, Eosinophil activation and function in health and disease, Immunol Ser
Agen, Danesi, Blandizzi, Costa, Stacchini et al., Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexpected role, Agents Actions
Anderson, Coyle, Th2 and 'Th2-like' cells in allergy and asthma: pharmacological perspectives, Trends Pharmacol Sci
Beigelman, Gunsten, Mikols, Vidavsky, Cannon et al., Azithromycin attenuates airway inflammation in a noninfectious mouse model of allergic asthma, Chest
Braman, The global burden of asthma, Chest
Bryskier, Agouridas, Chantot, New medical targets for macrolides, Exp Opin Invest Drugs
Caumes, Danis, New indications of ivermectin, Rev Med Interne
Coffman, Seymour, Hudak, Jackson, Rennick, Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice, Science
Corry, Grunig, Hadeiba, Kurup, Warnock et al., Requirementsfor allergen-induced airway hyperreactivity in T and B cell-deficient mice, Mol Med
Curtis, Byrd, Warnock, Kaltreider, Requirement of CD4-positive T cells for cellular recruitment to the lungs of mice in response to a particulate intratracheal antigen, J Clin Invest
Ej, Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators, Int J Antimicrob Agents
Elias, Lee, Zheng, Ma, Homer et al., New insights into the pathogenesis of asthma, J Clin Invest
Flohe, Brigelius-Flohe, Saliou, Traber, Packer, Redox regulation of NF-kappa B activation, Free Radic Biol Med
Fostera, Martinez-Moczygembab, Hustonb, Db, Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease, Pharmacol Ther
Hrvac ˇic, Bos ˇnjak, Bosnar, Ferenc ˇic ´z ˇ, Glojnaric et al., Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma, Eur J Pharmacol
Kimber, Stone, Dearman, Assessment of the inherent allergenic potential of proteins in mice, Environ Health Perspect
Kips, Cytokines in asthma, Eur Respir J
Kopf, Brombacher, Hodgkin, Ramsay, Milbourne et al., IL-5-deficient mice have a developmental defect in CD5? B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses, Immunity
Lee, Mcgarry, Farmer, Denzler, Larson et al., Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma, J Exp Med
Mikasa, Kita, Sawaki, Kunimatsu, Hamada et al., The anti-inflammatory effect of erythromycin in zymosan-induced peritonitis of mice, J Antimicrob Chemother
Ngoc, Gold, Tzianabos, Weiss, Celedon, Cytokines, allergy, and asthma, Curr Opin Allergy Clin Immunol
Peat, Toelle, Salome, Predictive nature of bronchial responsiveness and respiratory symptoms in a one year cohort study of Sydney schoolchildren, Eur Respir J
Pene, Rousset, Briere, Chretien, Bonnefoy et al., IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons a, g and prostaglandin E2, Proc Nat Acad Sci
Purkerson, Isakson, A two-signal model for regulation of immunoglobulin isotype switching, FASEB J
Stankiewicz, Cabaj, Moore, Millar, Ng Chie, Influence of ivermectin on cellular and humoral immune responses of lambs, Vet Immunol Immunopathol
Tarayre, Aliaga, Barbara, Villanova, Ballester et al., Cutaneously applied erythromycin base reduces various types of inflammatory reactions in mouse ear, Int J Tiss Reac
Toelle, Peat, Salome, Toward a definition of asthma for epidemiology, Am Rev Respir Dis
Umetsu, Dekruyff, TH1 and TH2 CD4? cells in human allergic diseases, J Allergy Clin Immunol
Van Rijt, Kuipers, Vos, Hijdra, Hoogsteden et al., A rapid flow cytometric method for determining the cellular composition of bronchoalveolar lavage fluid cells in mouse models of asthma, J Immunol Methods
Vanden Berghe, Plaisance, Boone, Bosscher, Schmitz et al., p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor, J Biol Chem
Wills-Karp, Immunologic basis of antigen-induced airway hyperresponsiveness, Annu Rev Immunol
Wills-Karp, Interleukin-13 in asthma pathogenesis, Immunol Rev
Wills-Karp, Luyimbazi, Xu, Schofield, Interleukin-13: central mediator of allergic asthma, Science
Zhang, Song, Ci, Ju, Li, Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice, Inflamm Res
Zhang, Song, Xiong, Ci, Li et al., Inhibitory effects of ivermectin on nitric oxide and prostaglandin E 2 production in LPS-stimulated RAW 264.7 macrophages, Int J Immunopharmacol
Zhou, Kang, Xie, Liu, Lou et al., Rapid nongenomic effects of glucocorticoids on allergic asthma reaction in the guinea pig, J Endocrinol
Zhu, Homer, Wang, Pulmonary expression of interleukin-13 causes inflammation, mucus hypersesretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production, J Clin Invest
{ 'indexed': {'date-parts': [[2023, 9, 20]], 'date-time': '2023-09-20T19:36:37Z', 'timestamp': 1695238597615},
'reference-count': 37,
'publisher': 'Springer Science and Business Media LLC',
'issue': '6',
'license': [ { 'start': { 'date-parts': [[2011, 1, 29]],
'date-time': '2011-01-29T00:00:00Z',
'timestamp': 1296259200000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'http://www.springer.com/tdm'}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'published-print': {'date-parts': [[2011, 6]]},
'DOI': '10.1007/s00011-011-0307-8',
'type': 'journal-article',
'created': {'date-parts': [[2011, 1, 28]], 'date-time': '2011-01-28T20:16:31Z', 'timestamp': 1296245791000},
'page': '589-596',
'source': 'Crossref',
'is-referenced-by-count': 77,
'title': 'Anti-inflammatory effects of ivermectin in mouse model of allergic asthma',
'prefix': '10.1007',
'volume': '60',
'author': [ {'given': 'Shuhan', 'family': 'Yan', 'sequence': 'first', 'affiliation': []},
{'given': 'Xinxin', 'family': 'Ci', 'sequence': 'additional', 'affiliation': []},
{'given': 'Na', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []},
{'given': 'Chi', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []},
{'given': 'Xiangchao', 'family': 'Li', 'sequence': 'additional', 'affiliation': []},
{'given': 'Xiao', 'family': 'Chu', 'sequence': 'additional', 'affiliation': []},
{'given': 'Jianhua', 'family': 'Li', 'sequence': 'additional', 'affiliation': []},
{'given': 'Xuming', 'family': 'Deng', 'sequence': 'additional', 'affiliation': []}],
'member': '297',
'published-online': {'date-parts': [[2011, 1, 29]]},
'reference': [ { 'key': '307_CR1',
'doi-asserted-by': 'crossref',
'first-page': '291',
'DOI': '10.1172/JCI17748',
'volume': '111',
'author': 'JA Elias',
'year': '2003',
'unstructured': 'Elias JA, Lee CG, Zheng T, Ma B, Homer RJ, Zhu Z. New insights into the '
'pathogenesis of asthma. J Clin Invest. 2003;111:291–7.',
'journal-title': 'J Clin Invest'},
{ 'key': '307_CR2',
'doi-asserted-by': 'crossref',
'first-page': '255',
'DOI': '10.1146/annurev.immunol.17.1.255',
'volume': '17',
'author': 'M Wills-Karp',
'year': '1999',
'unstructured': 'Wills-Karp M. Immunologic basis of antigen-induced airway '
'hyperresponsiveness. Annu Rev Immunol. 1999;17:255–81.',
'journal-title': 'Annu Rev Immunol'},
{ 'key': '307_CR3',
'doi-asserted-by': 'crossref',
'first-page': '324',
'DOI': '10.1016/0165-6147(94)90027-2',
'volume': '15',
'author': 'GP Anderson',
'year': '1994',
'unstructured': 'Anderson GP, Coyle AJ. Th2 and ‘Th2-like’ cells in allergy and asthma: '
'pharmacological perspectives. Trends Pharmacol Sci. 1994;15:324–32.',
'journal-title': 'Trends Pharmacol Sci'},
{ 'key': '307_CR4',
'doi-asserted-by': 'crossref',
'first-page': '4',
'DOI': '10.1378/chest.130.1_suppl.4S',
'volume': '130',
'author': 'SS Braman',
'year': '2006',
'unstructured': 'Braman SS. The global burden of asthma. Chest. 2006;130:4–12.',
'journal-title': 'Chest'},
{ 'key': '307_CR5',
'doi-asserted-by': 'crossref',
'first-page': '405',
'DOI': '10.1517/13543784.3.4.405',
'volume': '3',
'author': 'A Bryskier',
'year': '1994',
'unstructured': 'Bryskier A, Agouridas C, Chantot JF. New medical targets for macrolides. '
'Exp Opin Invest Drugs. 1994;3:405–10.',
'journal-title': 'Exp Opin Invest Drugs'},
{ 'key': '307_CR6',
'first-page': '77',
'volume': '4',
'author': 'JP Tarayre',
'year': '1987',
'unstructured': 'Tarayre JP, Aliaga M, Barbara M, Villanova G, Ballester R, '
'Tisne-Versailles J, et al. Cutaneously applied erythromycin base reduces '
'various types of inflammatory reactions in mouse ear. Int J Tiss Reac. '
'1987;4:77–85.',
'journal-title': 'Int J Tiss Reac'},
{ 'key': '307_CR7',
'doi-asserted-by': 'crossref',
'first-page': '339',
'DOI': '10.1093/jac/30.3.339',
'volume': '30',
'author': 'K Mikasa',
'year': '1992',
'unstructured': 'Mikasa K, Kita E, Sawaki M, Kunimatsu M, Hamada K, Konishi M, et al. The '
'anti-inflammatory effect of erythromycin in zymosan-induced peritonitis '
'of mice. J Antimicrob Chemother. 1992;30:339–48.',
'journal-title': 'J Antimicrob Chemother'},
{ 'key': '307_CR8',
'doi-asserted-by': 'crossref',
'first-page': '85',
'DOI': '10.1007/BF02027218',
'volume': '38',
'author': 'C Agen',
'year': '1993',
'unstructured': 'Agen C, Danesi R, Blandizzi C, Costa M, Stacchini B, Favini P, et al. '
'Macrolide antibiotics as antiinflammatory agents: roxithromycin in an '
'unexpected role. Agents Actions. 1993;38:85–90.',
'journal-title': 'Agents Actions'},
{ 'key': '307_CR9',
'doi-asserted-by': 'crossref',
'first-page': '12',
'DOI': '10.1016/j.ijantimicag.2007.08.001',
'volume': '31',
'author': 'EJ Giamarellos-Bourboulis',
'year': '2008',
'unstructured': 'Giamarellos-Bourboulis EJ. Macrolides beyond the conventional '
'antimicrobials: a class of potent immunomodulators. Int J Antimicrob '
'Agents. 2008;31:12–20.',
'journal-title': 'Int J Antimicrob Agents'},
{ 'key': '307_CR10',
'doi-asserted-by': 'crossref',
'first-page': '236',
'DOI': '10.1016/j.ejphar.2009.06.032',
'volume': '15',
'author': 'B Hrvačić',
'year': '2009',
'unstructured': 'Hrvačić B, Bošnjak B, Bosnar M, Ferenčić Ž, Glojnarić I, Eraković Haber '
'V. Clarithromycin suppresses airway hyperresponsiveness and inflammation '
'in mouse models of asthma. Eur J Pharmacol. 2009;15:236–43.',
'journal-title': 'Eur J Pharmacol'},
{ 'issue': '2',
'key': '307_CR11',
'doi-asserted-by': 'crossref',
'first-page': '498',
'DOI': '10.1378/chest.08-3056',
'volume': '136',
'author': 'A Beigelman',
'year': '2009',
'unstructured': 'Beigelman A, Gunsten S, Mikols CL, Vidavsky I, Cannon CL, Brody SL, et '
'al. Azithromycin attenuates airway inflammation in a noninfectious mouse '
'model of allergic asthma. Chest. 2009;136(2):498–506.',
'journal-title': 'Chest'},
{ 'key': '307_CR12',
'doi-asserted-by': 'crossref',
'first-page': '379',
'DOI': '10.1016/S0248-8663(01)00350-2',
'volume': '22',
'author': 'E Caumes',
'year': '2001',
'unstructured': 'Caumes E, Danis M. New indications of ivermectin. Rev Med Interne. '
'2001;22:379–84.',
'journal-title': 'Rev Med Interne'},
{ 'key': '307_CR13',
'doi-asserted-by': 'crossref',
'first-page': '347',
'DOI': '10.1016/0165-2427(94)05308-F',
'volume': '44',
'author': 'M Stankiewicz',
'year': '1995',
'unstructured': 'Stankiewicz M, Cabaj W, Jonas WE, Moore LG, Millar K, Ng Chie W. '
'Influence of ivermectin on cellular and humoral immune responses of '
'lambs. Vet Immunol Immunopathol. 1995;44:347–58.',
'journal-title': 'Vet Immunol Immunopathol'},
{ 'key': '307_CR14',
'doi-asserted-by': 'crossref',
'first-page': '354',
'DOI': '10.1016/j.intimp.2008.12.016',
'volume': '9',
'author': 'X Zhang',
'year': '2009',
'unstructured': 'Zhang X, Song Y, Xiong H, Ci X, Li H, Yu L, et al. Inhibitory effects of '
'ivermectin on nitric oxide and prostaglandin E2 production in '
'LPS-stimulated RAW 264.7 macrophages. Int J Immunopharmacol. '
'2009;9:354–9.',
'journal-title': 'Int J Immunopharmacol'},
{ 'key': '307_CR15',
'doi-asserted-by': 'crossref',
'first-page': '524',
'DOI': '10.1007/s00011-008-8007-8',
'volume': '57',
'author': 'X Zhang',
'year': '2008',
'unstructured': 'Zhang X, Song Y, Ci X, An N, Ju Y, Li H, et al. Ivermectin inhibits '
'LPS-induced production of inflammatory cytokines and improves '
'LPS-induced survival in mice. Inflamm Res. 2008;57:524–9.',
'journal-title': 'Inflamm Res'},
{ 'key': '307_CR16',
'doi-asserted-by': 'crossref',
'first-page': '111',
'DOI': '10.1016/j.jim.2004.03.004',
'volume': '288',
'author': 'LS Rijt Van',
'year': '2004',
'unstructured': 'Van Rijt LS, Kuipers H, Vos N, Hijdra D, Hoogsteden HC, Lambrecht BN. A '
'rapid flow cytometric method for determining the cellular composition of '
'bronchoalveolar lavage fluid cells in mouse models of asthma. J Immunol '
'Methods. 2004;288:111–21.',
'journal-title': 'J Immunol Methods'},
{ 'key': '307_CR17',
'doi-asserted-by': 'crossref',
'first-page': 'R1',
'DOI': '10.1677/joe.0.177R001',
'volume': '177',
'author': 'J Zhou',
'year': '2003',
'unstructured': 'Zhou J, Kang Z, Xie Q, Liu C, Lou S, Chen Y, et al. Rapid nongenomic '
'effects of glucocorticoids on allergic asthma reaction in the guinea '
'pig. J Endocrinol. 2003;177:R1–4.',
'journal-title': 'J Endocrinol'},
{ 'key': '307_CR18',
'doi-asserted-by': 'crossref',
'first-page': '6880',
'DOI': '10.1073/pnas.85.18.6880',
'volume': '85',
'author': 'J Pene',
'year': '1988',
'unstructured': 'Pene J, Rousset F, Briere F, Chretien I, Bonnefoy JY, Spits H, et al. '
'IgE production by normal human lymphocytes is induced by interleukin 4 '
'and suppressed by interferons a, g and prostaglandin E2. Proc Nat Acad '
'Sci USA. 1988;85:6880–4.',
'journal-title': 'Proc Nat Acad Sci USA'},
{ 'key': '307_CR19',
'doi-asserted-by': 'crossref',
'first-page': '1',
'DOI': '10.1016/S0091-6749(97)70186-6',
'volume': '100',
'author': 'DT Umetsu',
'year': '1997',
'unstructured': 'Umetsu DT, DeKruyff RH. TH1 and TH2 CD4+ cells in human allergic '
'diseases. J Allergy Clin Immunol. 1997;100:1–6.',
'journal-title': 'J Allergy Clin Immunol'},
{ 'key': '307_CR20',
'doi-asserted-by': 'crossref',
'first-page': '344',
'DOI': '10.1007/s008940050092',
'volume': '4',
'author': 'DB Corry',
'year': '1998',
'unstructured': 'Corry DB, Grunig G, Hadeiba H, Kurup VP, Warnock ML, Sheppard D, et al. '
'Requirementsfor allergen-induced airway hyperreactivity in T and B '
'cell-deficient mice. Mol Med. 1998;4:344–55.',
'journal-title': 'Mol Med'},
{ 'key': '307_CR21',
'doi-asserted-by': 'crossref',
'first-page': '1244',
'DOI': '10.1172/JCI115428',
'volume': '88',
'author': 'JL Curtis',
'year': '1991',
'unstructured': 'Curtis JL, Byrd PK, Warnock ML, Kaltreider HB. Requirement of '
'CD4-positive T cells for cellular recruitment to the lungs of mice in '
'response to a particulate intratracheal antigen. J Clin Invest. '
'1991;88:1244–54.',
'journal-title': 'J Clin Invest'},
{ 'key': '307_CR22',
'doi-asserted-by': 'crossref',
'unstructured': 'Kips JC. Cytokines in asthma. Eur Respir J. 2001;18:24–33.',
'DOI': '10.1183/09031936.01.00229601'},
{ 'key': '307_CR23',
'doi-asserted-by': 'crossref',
'first-page': '175',
'DOI': '10.1111/j.0105-2896.2004.00215.x',
'volume': '202',
'author': 'M Wills-Karp',
'year': '2004',
'unstructured': 'Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev. '
'2004;202:175–90.',
'journal-title': 'Immunol Rev'},
{ 'key': '307_CR24',
'doi-asserted-by': 'crossref',
'first-page': '161',
'DOI': '10.1097/01.all.0000162309.97480.45',
'volume': '5',
'author': 'LP Ngoc',
'year': '2005',
'unstructured': 'Ngoc LP, Gold DR, Tzianabos AO, Weiss ST, Celedon JC. Cytokines, '
'allergy, and asthma. Curr Opin Allergy Clin Immunol. 2005;5:161–6.',
'journal-title': 'Curr Opin Allergy Clin Immunol'},
{ 'key': '307_CR25',
'doi-asserted-by': 'crossref',
'first-page': '2258',
'DOI': '10.1126/science.282.5397.2258',
'volume': '282',
'author': 'M Wills-Karp',
'year': '1998',
'unstructured': 'Wills-Karp M, Luyimbazi J, Xu X, Schofield B. Interleukin-13: central '
'mediator of allergic asthma. Science. 1998;282:2258–61.',
'journal-title': 'Science'},
{ 'key': '307_CR26',
'doi-asserted-by': 'crossref',
'first-page': '3245',
'DOI': '10.1096/fasebj.6.14.1385241',
'volume': '6',
'author': 'J Purkerson',
'year': '1992',
'unstructured': 'Purkerson J, Isakson P. A two-signal model for regulation of '
'immunoglobulin isotype switching. FASEB J. 1992;6:3245–52.',
'journal-title': 'FASEB J'},
{ 'key': '307_CR27',
'doi-asserted-by': 'crossref',
'first-page': '227',
'DOI': '10.1289/ehp.5703',
'volume': '111',
'author': 'I Kimber',
'year': '2003',
'unstructured': 'Kimber I, Stone S, Dearman RJ. Assessment of the inherent allergenic '
'potential of proteins in mice. Environ Health Perspect. 2003;111:227–31.',
'journal-title': 'Environ Health Perspect'},
{ 'key': '307_CR28',
'first-page': '137',
'volume': '57',
'author': 'RI Abu-Ghazaleh',
'year': '1992',
'unstructured': 'Abu-Ghazaleh RI, Kita H, Gleich GJ. Eosinophil activation and function '
'in health and disease. Immunol Ser. 1992;57:137–67.',
'journal-title': 'Immunol Ser'},
{ 'key': '307_CR29',
'doi-asserted-by': 'crossref',
'first-page': '308',
'DOI': '10.1126/science.2787531',
'volume': '245',
'author': 'RL Coffman',
'year': '1898',
'unstructured': 'Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D. Antibody to '
'interleukin-5 inhibits helminth-induced eosinophilia in mice. Science. '
'1898;245:308–10.',
'journal-title': 'Science'},
{ 'key': '307_CR30',
'doi-asserted-by': 'crossref',
'first-page': '15',
'DOI': '10.1016/S1074-7613(00)80294-0',
'volume': '4',
'author': 'M Kopf',
'year': '1996',
'unstructured': 'Kopf M, Brombacher F, Hodgkin PD, Ramsay AJ, Milbourne EA, Dai WJ, et '
'al. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells '
'and lack eosinophilia but have normal antibody and cytotoxic T cell '
'responses. Immunity. 1996;4:15–24.',
'journal-title': 'Immunity'},
{ 'key': '307_CR31',
'doi-asserted-by': 'crossref',
'first-page': '2143',
'DOI': '10.1084/jem.185.12.2143',
'volume': '185',
'author': 'JJ Lee',
'year': '1997',
'unstructured': 'Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE, et '
'al. Interleukin-5 expression in the lung epithelium of transgenic mice '
'leads to pulmonary changes pathognomonic of asthma. J Exp Med. '
'1997;185:2143–56.',
'journal-title': 'J Exp Med'},
{ 'key': '307_CR32',
'doi-asserted-by': 'crossref',
'first-page': '253',
'DOI': '10.1016/S0163-7258(02)00220-6',
'volume': '94',
'author': 'PS Fostera',
'year': '2002',
'unstructured': 'Fostera PS, Martinez-Moczygembab M, Hustonb DP, Corry DB. '
'Interleukins-4, -5, and -13: emerging therapeutic targets in allergic '
'disease. Pharmacol Ther. 2002;94:253–64.',
'journal-title': 'Pharmacol Ther'},
{ 'key': '307_CR33',
'doi-asserted-by': 'crossref',
'first-page': '633',
'DOI': '10.1164/ajrccm/146.3.633',
'volume': '146',
'author': 'BG Toelle',
'year': '1992',
'unstructured': 'Toelle BG, Peat JK, Salome CM. Toward a definition of asthma for '
'epidemiology. Am Rev Respir Dis. 1992;146:633–7.',
'journal-title': 'Am Rev Respir Dis'},
{ 'key': '307_CR34',
'first-page': '662',
'volume': '6',
'author': 'J Peat',
'year': '1993',
'unstructured': 'Peat J, Toelle B, Salome C. Predictive nature of bronchial '
'responsiveness and respiratory symptoms in a one year cohort study of '
'Sydney schoolchildren. Eur Respir J. 1993;6:662–9.',
'journal-title': 'Eur Respir J'},
{ 'key': '307_CR35',
'doi-asserted-by': 'crossref',
'first-page': '779',
'DOI': '10.1172/JCI5909',
'volume': '103',
'author': 'Z Zhu',
'year': '1999',
'unstructured': 'Zhu Z, Homer RJ, Wang Z. Pulmonary expression of interleukin-13 causes '
'inflammation, mucus hypersesretion, subepithelial fibrosis, physiologic '
'abnormalities, and eotaxin production. J Clin Invest. 1999;103:779–88.',
'journal-title': 'J Clin Invest'},
{ 'key': '307_CR36',
'doi-asserted-by': 'crossref',
'first-page': '1115',
'DOI': '10.1016/S0891-5849(96)00501-1',
'volume': '22',
'author': 'L Flohé',
'year': '1997',
'unstructured': 'Flohé L, Brigelius-Flohé R, Saliou C, Traber MG, Packer L. Redox '
'regulation of NF-kappa B activation. Free Radic Biol Med. '
'1997;22:1115–26.',
'journal-title': 'Free Radic Biol Med'},
{ 'key': '307_CR37',
'doi-asserted-by': 'crossref',
'first-page': '3285',
'DOI': '10.1074/jbc.273.6.3285',
'volume': '273',
'author': 'W Berghe Vanden',
'year': '1998',
'unstructured': 'Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers '
'W. p38 and extracellular signal-regulated kinase mitogen-activated '
'protein kinase pathways are required for nuclear factor-kappaB p65 '
'transactivation mediated by tumor necrosis factor. J Biol Chem. '
'1998;273:3285–90.',
'journal-title': 'J Biol Chem'}],
'container-title': 'Inflammation Research',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'http://link.springer.com/content/pdf/10.1007/s00011-011-0307-8.pdf',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'http://link.springer.com/article/10.1007/s00011-011-0307-8/fulltext.html',
'content-type': 'text/html',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'http://link.springer.com/content/pdf/10.1007/s00011-011-0307-8',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2019, 6, 8]],
'date-time': '2019-06-08T06:01:31Z',
'timestamp': 1559973691000},
'score': 1,
'resource': {'primary': {'URL': 'http://link.springer.com/10.1007/s00011-011-0307-8'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2011, 1, 29]]},
'references-count': 37,
'journal-issue': {'issue': '6', 'published-print': {'date-parts': [[2011, 6]]}},
'alternative-id': ['307'],
'URL': 'http://dx.doi.org/10.1007/s00011-011-0307-8',
'relation': {},
'ISSN': ['1023-3830', '1420-908X'],
'subject': ['Pharmacology', 'Immunology'],
'container-title-short': 'Inflamm. Res.',
'published': {'date-parts': [[2011, 1, 29]]}}
